John Allan Ellerton

5.4k citations
26 papers · 4.3k · 3 hit papers · h-index 18

Impact in

  • Hematology top 0.5%
    • Acute Myeloid Leukemia Research
  • Oncology top 2%
    • HER2/EGFR in Cancer Research
    • Cancer Immunotherapy and Biomarkers
    • Cancer Treatment and Pharmacology

Papers in

    • Lung Cancer Research Studies 4
    • Cancer Immunotherapy and Biomarkers 3
    • Acute Myeloid Leukemia Research 4

John Allan Ellerton

26 papers receiving 4.2k citations

John Allan Ellerton's Hit Papers

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study 2020 · 668 citations
6680+8+16Years since publication50010001.5k

Peers

John Allan Ellerton
Comparison fields: 5 of 105
  • Hematology 1.5k
  • Oncology 1.6k
  • Genetics 439
  • Cancer Research 456
  • Pulmonary and Respiratory Medicine 549
Replace Meredith A. Goldwasser with:
Meredith A. Goldwasser United States
Alexander Kiani Germany
Javier García-Conde Spain
Karel A. Dicke United States
Tariq I. Mughal United States
Ben L. Sanford United States
Nathalie Contentin France
Peter B. Langmuir United States
Gernot Seipelt Germany
Robert Duffy Legare United States
John Allan Ellerton relative to Meredith A. Goldwasser United States Meredith A. Goldwasser's profile →
Citations per field
00.5×1.5×
Meredith A. Goldwasser · 1×
Citations per year

Countries citing papers authored by John Allan Ellerton

Since Specialization
Citations

This map shows the geographic impact of John Allan Ellerton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Allan Ellerton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Allan Ellerton more than expected).

Fields of papers citing papers by John Allan Ellerton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Allan Ellerton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Allan Ellerton. The network helps show where John Allan Ellerton may publish in the future.

Co-authors

The 25 scholars most cited alongside John Allan Ellerton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Allan Ellerton Line = papers co-authored together John Allan Ellerton links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B
Hit paper breakdown →
20021518
2
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study
Hit paper breakdown →
2020668
3
Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial
Hit paper breakdown →
2017485
4 1994478
5 2002353
6 2005146
7 2010100
8 199592
9
Are the elderly predisposed to toxicity from cancer chemotherapy? An investigation using data from the Eastern Cooperative Oncology Group.
198087
10 199378
11 202070
12 200844
13 199937
14 199332
15 202429
16 199120
17 199218
18 201618
19 201717
20 197915

About John Allan Ellerton

John Allan Ellerton is a scholar working on Oncology, Hematology, Genetics, Surgery and Cancer Research, having authored 26 papers that have together received 4.3k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (5 papers), Acute Myeloid Leukemia Research (4 papers), Lung Cancer Research Studies (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Hemoglobinopathies and Related Disorders (2 papers), Urinary and Genital Oncology Studies (2 papers), Cancer therapeutics and mechanisms (2 papers) and Fungal Infections and Studies (1 paper). The work is most often cited by research in Hematology (1.5k citations), Oncology (1.6k citations), Genetics (439 citations), Cancer Research (456 citations) and Pulmonary and Respiratory Medicine (549 citations). John Allan Ellerton has collaborated with scholars based in United States, Belgium and South Korea. Frequent co-authors include Charles Alan Schiffer, Rosalie Odchimar-Reissig, Jimmie C. Holland, Alice B. Kornblith, Richard A. Larson, Erin P. Demakos, Bayard L. Powell, Lewis R. Silverman, Carlos M. DeCastro and James F. Holland. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, The Lancet Oncology, Clinical Cancer Research and European Urology Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact